These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 10769654
1. In vitro growth of TS/A adenocarcinoma and of the gene transfected TS/A-IL4 line on biological substrates. Pacor S, Magnarin M, Carotenuto ME, Spessotto P, Zabucchi G, Sava G. Anticancer Res; 2000; 20(1A):191-6. PubMed ID: 10769654 [Abstract] [Full Text] [Related]
6. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status. Douin-Echinard V, Bornes S, Rochaix P, Tilkin AF, Peron JM, Bonnet J, Favre G, Couderc B. Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533 [Abstract] [Full Text] [Related]
7. Induction of T-cell antitumor immunity and protection against tumor growth by secretion of soluble human CD70 molecules. Cormary C, Gonzalez R, Faye JC, Favre G, Tilkin-Mariamé AF. Cancer Gene Ther; 2004 Jul; 11(7):497-507. PubMed ID: 15153937 [Abstract] [Full Text] [Related]
9. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory. Mortara L, Castellani P, Meazza R, Tosi G, De Lerma Barbaro A, Procopio FA, Comes A, Zardi L, Ferrini S, Accolla RS. Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3435-43. PubMed ID: 16740768 [Abstract] [Full Text] [Related]
10. HSG cells differentiated by culture on extracellular matrix involves induction of S-adenosylmethione decarboxylase and ornithine decarboxylase. Lam K, Zhang L, Bewick M, Lafrenie RM. J Cell Physiol; 2005 May 01; 203(2):353-61. PubMed ID: 15521072 [Abstract] [Full Text] [Related]
12. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. Tobin SW, Douville K, Benbow U, Brinckerhoff CE, Memoli VA, Arrick BA. Oncogene; 2002 Jan 03; 21(1):108-18. PubMed ID: 11791181 [Abstract] [Full Text] [Related]
13. Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells. Meazza R, Comes A, Orengo AM, Ferrini S, Accolla RS. Eur J Immunol; 2003 May 03; 33(5):1183-92. PubMed ID: 12731043 [Abstract] [Full Text] [Related]
14. Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions. Mortara L, Frangione V, Castellani P, De Lerma Barbaro A, Accolla RS. Int Immunol; 2009 Jun 03; 21(6):655-65. PubMed ID: 19395374 [Abstract] [Full Text] [Related]
15. In vivo induction of antitumor immunity and protection against tumor growth by injection of CD154-expressing tumor cells. Grangeon C, Cormary C, Douin-Echinard V, Favre G, Couderc B, Tilkin-Mariamé AF. Cancer Gene Ther; 2002 Mar 03; 9(3):282-8. PubMed ID: 11896445 [Abstract] [Full Text] [Related]
19. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis. Hollmann CA, Kittrell FS, Medina D, Butel JS. Oncogene; 2001 Nov 15; 20(52):7645-57. PubMed ID: 11753642 [Abstract] [Full Text] [Related]
20. Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis. Langley RR, Ramirez KM, Tsan RZ, Van Arsdall M, Nilsson MB, Fidler IJ. Cancer Res; 2003 Jun 01; 63(11):2971-6. PubMed ID: 12782605 [Abstract] [Full Text] [Related] Page: [Next] [New Search]